ARK Investment Management Holds 8.7% Stake in Adaptive Biotech

Ticker: ADPT · Form: SC 13G/A · Filed: Jan 29, 2024 · CIK: 1478320

Adaptive Biotechnologies Corp SC 13G/A Filing Summary
FieldDetail
CompanyAdaptive Biotechnologies Corp (ADPT)
Form TypeSC 13G/A
Filed DateJan 29, 2024
Risk Levellow
Pages3
Reading Time4 min
Sentimentneutral

Complexity: simple

Sentiment: neutral

Topics: institutional-ownership, amendment, biotech, fund-holding

TL;DR

**ARK still owns a big chunk of Adaptive Biotech, 8.7% as of year-end!**

AI Summary

ARK Investment Management LLC, led by Cathie Wood, filed an amended SC 13G/A on January 29, 2024, disclosing its ownership in Adaptive Biotechnologies Corp. As of December 31, 2023, ARK beneficially owned 12,806,513 shares of common stock, representing 8.7% of the company. This is an update to their previous filing, indicating a significant, though slightly reduced, stake in the biotech firm, which matters to investors as ARK's movements often influence market sentiment and trading activity for the stocks they hold.

Why It Matters

This filing confirms ARK's continued significant investment in Adaptive Biotechnologies, signaling their ongoing conviction in the company's future, which can influence other investors.

Risk Assessment

Risk Level: low — This filing is a routine update on institutional ownership and does not indicate any immediate negative risks for the company or its investors.

Analyst Insight

A smart investor would note ARK's continued, albeit slightly adjusted, significant stake in Adaptive Biotechnologies, and consider it as a factor in their own due diligence, but not as the sole reason for investment.

Key Numbers

  • 12,806,513 — Shares Beneficially Owned (The total number of common stock shares of Adaptive Biotechnologies Corp owned by ARK Investment Management LLC as of December 31, 2023.)
  • 8.7% — Percentage of Class (The percentage of Adaptive Biotechnologies Corp's common stock class beneficially owned by ARK Investment Management LLC.)
  • December 31, 2023 — Date of Event (The date as of which the ownership stake was calculated for this filing.)
  • January 29, 2024 — Filing Date (The date this SC 13G/A amendment was filed with the SEC.)

Key Players & Entities

  • ARK Investment Management LLC (company) — the reporting person and institutional investor
  • Adaptive Biotechnologies Corp (company) — the subject company in which shares are held
  • Delaware (place) — place of organization for ARK Investment Management LLC
  • Cathie Wood (person) — founder and CEO of ARK Investment Management LLC

Forward-Looking Statements

  • ARK Investment Management LLC will continue to be a significant holder of Adaptive Biotechnologies Corp shares. (Adaptive Biotechnologies Corp) — medium confidence, target: December 31, 2024
  • ARK's continued ownership may attract other institutional investors to Adaptive Biotechnologies Corp. (Adaptive Biotechnologies Corp) — low confidence, target: June 30, 2024

FAQ

What is the purpose of this SC 13G/A filing by ARK Investment Management LLC?

This SC 13G/A filing is an amendment (Amendment No. 1) to a previous Schedule 13G, updating the disclosure of ARK Investment Management LLC's beneficial ownership in Adaptive Biotechnologies Corporation as of December 31, 2023.

How many shares of Adaptive Biotechnologies Corp does ARK Investment Management LLC beneficially own, and what percentage of the company does this represent?

As of December 31, 2023, ARK Investment Management LLC beneficially owns 12,806,513 shares of Adaptive Biotechnologies Corp common stock, which represents 8.7% of the class of securities.

What type of voting and dispositive power does ARK Investment Management LLC have over these shares?

ARK Investment Management LLC has sole voting power over 12,806,513 shares and sole dispositive power over 12,806,513 shares. They report zero shared voting or shared dispositive power.

When was the event date that triggered this filing?

The date of the event which requires the filing of this statement was December 31, 2023, as stated on the cover page of the filing.

Under which rule was this Schedule 13G filed?

This Schedule 13G was filed under Rule 13d-1(b), as indicated by the checked box on the cover page.

Filing Stats: 939 words · 4 min read · ~3 pages · Grade level 8 · Accepted 2024-01-29 16:00:59

Filing Documents

(a) Name of issuer

Item 1(a) Name of issuer: Adaptive Biotechnologies Corporation

(b) Address of issuer's principal executive offices

Item 1(b) Address of issuer's principal executive offices: 1165 Eastlake Avenue East Seattle, Washington 98109

(a) Name of person filing

Item 2(a) Name of person filing: ARK Investment Management LLC

(b) Address or principal business office or, if none,

Item 2(b) Address or principal business office or, if none, residence: ARK Investment Management LLC 200 Central Avenue St. Petersburg, FL 33701

(c) Citizenship

Item 2(c) Citizenship: Delaware, United States

(d) Title of class of securities

Item 2(d) Title of class of securities: Common stock

(e) CUSIP No

Item 2(e) CUSIP No.: 00650F109

If this statement is filed pursuant to §§ 240.13d-1(b) or

Item 3. If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o); (b) Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); (c) Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c); (d) Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8); (e) An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E); (f) An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F); (g) A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G); (h) A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J); (k) Group, in accordance with § 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____ CUSIP No. 00650F109 13G Page 4 of 5 Pages

Ownership

Item 4. Ownership (a) Amount beneficially owned: 12,806,513 (b) Percent of class: 8.85% (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote: 12,806,513 (ii) Shared power to vote or to direct the vote: 0 (iii) Sole power to dispose or to direct the disposition of: 12,806,513 (iv) Shared power to dispose or to direct the disposition of: 0

Ownership of 5 Percent or Less of a Class

Item 5. Ownership of 5 Percent or Less of a Class. Not applicable.

Ownership of More than 5 Percent on Behalf of Another Person

Item 6. Ownership of More than 5 Percent on Behalf of Another Person. To the knowledge of the Reporting Person, no other person has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, a number of the shares which represents more than five percent of the number of outstanding class of the shares. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. Not applicable.

Identification and Classification of Members of the Group

Item 8. Identification and Classification of Members of the Group. Not applicable.

Notice of Dissolution of Group

Item 9. Notice of Dissolution of Group. Not applicable. CUSIP No. 00650F109 13G Page 5 of 5 Pages

Certifications

Item 10. Certifications. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. The reporting persons agree that this statement is filed on behalf of each of them. Dated: January 29, 2024 ARK Investment Management LLC By: /s/ Kellen Carter Name: Kellen Carter Title: Chief Compliance Officer

View Full Filing

View this SC 13G/A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.